Thermo Fisher Scientific Inc (NYSE:TMO)

242.50
Delayed Data
As of Sep 20
 +1.44 / +0.60%
Today’s Change
181.51
Today|||52-Week Range
244.37
+27.71%
Year-to-Date
Orbimed Advisors Llc Buys Tricida Inc, Anthem Inc, Allergan PLC, Sells Regeneron ...
Sep 20 / GuruFocus News - Paid Partner Content
Stock Market News For Sep 10, 2018
Sep 10 / Zacks.com - Paid Partner Content
Here's Why You Should Hold on to Roper (ROP) Stock for Now
Sep 18 / Zacks.com - Paid Partner Content
Thermo Fisher to Acquire BD's Advanced Bioprocessing Unit
Sep 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close241.06
Today’s open241.84
Day’s range241.00 - 242.93
Volume1,016,840
Average volume (3 months)1,290,607
Market cap$97.1B
Data as of 4:00pm ET, 09/20/2018

Growth & Valuation

Earnings growth (last year)+9.82%
Earnings growth (this year)+15.68%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+14.47%
P/E ratio40.9
Price/Sales3.61
Price/Book3.81

Competitors

 Today’s
change
Today’s
% change
DHRDanaher Corp+0.46+0.43%
AAgilent Technologies...+1.57+2.26%
MTDMettler-Toledo Inter...+1.34+0.22%
WATWaters Corp+0.62+0.32%
Data as of 4:02pm ET, 09/20/2018

Financials

Next reporting dateOctober 24, 2018
EPS forecast (this quarter)$2.55
Annual revenue (last year)$20.9B
Annual profit (last year)$2.2B
Net profit margin10.65%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Marc N. Casper
Chief Operating Officer &
Executive Vice President
Mark P. Stevenson
Corporate headquarters
Waltham, Massachusetts

Forecasts